S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
NYSE:NVST

Envista (NVST) Stock Forecast, Price & News

$41.33
-1.59 (-3.70%)
(As of 05/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$40.91
$43.28
50-Day Range
$39.52
$50.90
52-Week Range
$37.60
$52.03
Volume
1.68 million shs
Average Volume
1.88 million shs
Market Capitalization
$6.72 billion
P/E Ratio
21.41
Dividend Yield
N/A
Beta
1.64
30 days | 90 days | 365 days | Advanced Chart
Receive NVST News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

Envista logo

About Envista

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Employees
11,200
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.51 billion
Cash Flow
$3.09 per share
Book Value
$25.15 per share

Profitability

Net Income
$340.50 million
Pretax Margin
10.00%

Debt

Price-To-Earnings

Miscellaneous

Free Float
161,382,000
Market Cap
$6.72 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/04/2022
Today
5/18/2022
Next Earnings (Estimated)
8/02/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.78 out of 5 stars

Medical Sector

985th out of 1,426 stocks

Dental Equipment & Supplies Industry

5th out of 6 stocks

Analyst Opinion: 3.4Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -













Envista (NYSE:NVST) Frequently Asked Questions

Is Envista a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Envista in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Envista stock.
View analyst ratings for Envista
or view top-rated stocks.

When is Envista's next earnings date?

Envista is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Envista
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) released its quarterly earnings data on Wednesday, May, 4th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.44 by $0.03. The business earned $631.40 million during the quarter, compared to analyst estimates of $629.30 million. Envista had a trailing twelve-month return on equity of 8.54% and a net margin of 13.06%. Envista's quarterly revenue was down 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.54 EPS.
View Envista's earnings history
.

What price target have analysts set for NVST?

4 brokerages have issued twelve-month price targets for Envista's shares. Their forecasts range from $48.00 to $56.00. On average, they anticipate Envista's stock price to reach $51.75 in the next year. This suggests a possible upside of 25.2% from the stock's current price.
View analysts' price targets for Envista
or view top-rated stocks among Wall Street analysts.

Who are Envista's key executives?
Envista's management team includes the following people:
  • Mr. Amir Aghdaei, Pres, CEO & Director (Age 63, Pay $4.5M) (LinkedIn Profile)
  • Mr. Howard H. Yu, Sr. VP & CFO (Age 49, Pay $1.23M) (LinkedIn Profile)
  • Mr. Mark E. Nance, Sr. VP, Gen. Counsel & Sec. (Age 53, Pay $1.1M) (LinkedIn Profile)
  • Mr. Patrik Eriksson, Sr. VP & Pres of Nobel Biocare (Age 54, Pay $1.17M)
  • Mr. Jean-Claude E. Kyrillos, Sr. VP of Diagnostics & Digital Solutions (Age 58, Pay $1.01M)
  • Kari-Lyn Moore, VP & Chief Accounting Officer
  • Juan Arbona, Chief Compliance Officer
  • Mr. Mischa M. Reis, Sr. VP of Strategy & Corp. Devel. (Age 49) (LinkedIn Profile)
  • Mr. Filippo Impieri, Sr. VP of Special Markets
  • Ms. Claudia Ortiz, Sr. VP of Regulatory Affairs & Quality Assurance
What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista CEO Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among Envista's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

(NVST) raised $603 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,800,000 shares at a price of $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

What is Envista's stock symbol?

Envista trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVST."

Who are Envista's major shareholders?

Envista's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.29%), Massachusetts Financial Services Co. MA (4.84%), Ariel Investments LLC (3.55%), Dimensional Fund Advisors LP (2.71%), Boston Partners (1.48%) and Montrusco Bolton Investments Inc. (1.41%). Company insiders that own Envista stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance and Mischa Reis.
View institutional ownership trends for Envista
.

Which major investors are selling Envista stock?

NVST stock was sold by a variety of institutional investors in the last quarter, including Paradice Investment Management LLC, Boston Partners, Ariel Investments LLC, Zurcher Kantonalbank Zurich Cantonalbank , Eversept Partners LP, Polar Capital Holdings Plc, Renaissance Technologies LLC, and Sei Investments Co.. Company insiders that have sold Envista company stock in the last year include Amir Aghdaei, Curt W Bludworth, Howard H Yu, Jeffrey Kappler, Mark E Nance, and Mischa Reis.
View insider buying and selling activity for Envista
or view top insider-selling stocks.

Which major investors are buying Envista stock?

NVST stock was purchased by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Jennison Associates LLC, Principal Financial Group Inc., Leeward Investments LLC MA, Alyeska Investment Group L.P., TimesSquare Capital Management LLC, abrdn plc, and Loomis Sayles & Co. L P.
View insider buying and selling activity for Envista
or or view top insider-buying stocks.

How do I buy shares of Envista?

Shares of NVST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Envista's stock price today?

One share of NVST stock can currently be purchased for approximately $41.33.

How much money does Envista make?

Envista has a market capitalization of $6.72 billion and generates $2.51 billion in revenue each year. The company earns $340.50 million in net income (profit) each year or $1.929990 on an earnings per share basis.

How many employees does Envista have?

Envista employs 11,200 workers across the globe.

What is Envista's official website?

The official website for Envista is www.envistaco.com.

How can I contact Envista?

Envista's mailing address is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. The company can be reached via phone at 714-817-7000, via email at [email protected], or via fax at 714-817-5450.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.